# FDA Inspection 1299372 - Albert Oriol Rocafiguera, MD - December 05, 2025

Source: https://www.keypedia.com/records/fda_inspections/albert-oriol-rocafiguera-md/615479fc-85c5-453a-b85d-a0bf20abc91c
Source feed: FDA_Inspections

> FDA Inspection 1299372 for Albert Oriol Rocafiguera, MD on December 05, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1299372
- Company Name: Albert Oriol Rocafiguera, MD
- Inspection Date: 2025-12-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1299372 - 2025-12-05](https://www.keypedia.com/records/fda_inspections/albert-oriol-rocafiguera-md/bc6073e6-b57e-4a3d-b575-eb1892b8a748)
- [FDA Inspection 1231776 - 2024-02-22](https://www.keypedia.com/records/fda_inspections/albert-oriol-rocafiguera-md/2de2153f-3e6c-4556-8ff0-ac4569683f1f)
- [FDA Inspection 930720 - 2015-05-22](https://www.keypedia.com/records/fda_inspections/albert-oriol-rocafiguera-md/d5d811ac-fc62-4c6e-80af-49bee8e26b6d)

Company: https://www.keypedia.com/companies/albert-oriol-rocafiguera-md/7b0e6e6b-50e3-4bc2-a857-1ef4c9c9a766